Cooperation with University of Gdansk and New England Biolabs Ltd. (USA)

BioVentures InstituteSp. z o.o. continues a long term cooperation with University of Gdansk and New England Biolabs Ltd. (USA), a world leader in the development and sales of enzymatic tools for recombinant DNA technologies. Our common project in the field of restriction endonucleases has resulted in solving a longstanding riddle of two RM.TaqII specificities, discovering a third RM system (RM.TaqIII) from T. aquaticus YT-1. Results were published in a high Impact Factor (10.2) journal – Nucleic Acid Research 2017, DOI: 10.1093/nar/gkx599. Among the authors is a Nobel Prize Nominee – prof. Richard Roberts..

The third restriction–modification syste
Download • 12.16MB

Recent Posts

See All

Patent for EU

Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes has been granted with European Union p